Technological development and patent analysis: The case of biopharmacy in the world and in Latin America (2022)
Alejandro Barragán-Ocaña (Author)
Rubén Oliver-Espinoza (Author)
María del Pilar Longar-Blanco (Author)
Hortensia Gómez-Viquez (Author)
Tapuya: Latin American Science, Technology and Society
Volume: 5
Issue: 1
Physical Details: Digital journal
Language: English
Pharmaceuticals, biotechnology, and technological advances are currently a new paradigm with ample potential to provide therapeutic solutions to multiple diseases. The purpose of this study was to survey granted patents related to biopharmaceutical products. The most important results show that most of these inventions are concentrated in the United States, and European and Asian countries, and that US companies are the clear leaders in this area of knowledge, reaffirming its position as one of the most important technological markets in the world. Additionally, the technological classes, established according to search criteria, that have shown the most progress over time has to do with medicinal preparations containing antigens or antibodies, as well as those associated with peptides. Finally, the role of the Latin American market is not relevant for the production of this group of technologies; consequently, it is important to define strategies for their inclusion in countries in the region and to promote cooperation in terms of research and development. This course of action will provide the region with the possibility of increasing technological capabilities that will allow it to innovate within the sector.
...MoreSimilar Citations
Chapter
Kahn, Jonathan;
(2011)
Inventing Race as a Genetic Commodity in Biotechnology Patents
(/isis/citation/CBB001221562/)
Book
Myles W. Jackson;
(2015)
The Genealogy of a Gene: Patents, HIV/AIDS, and Race
(/isis/citation/CBB193037134/)
Article
Sturchio, Jeffrey L.;
Galambos, L.;
(1998)
Pharmaceutical firms and the transition to biotechnology: A study in strategic innovation
(/isis/citation/CBB001180879/)
Article
Pottage, Alain;
(October 2011)
Law machines: Scale models, forensic materiality and the making of modern patent law
(/isis/citation/CBB306887041/)
Chapter
Hayden, Cori;
(2011)
No Patent, No Generic: Pharmaceutical Access and the Politics of the Copy
(/isis/citation/CBB001221561/)
Article
Waldby, Catherine;
(2009)
Singapore Biopolis: Bare Life in the City-State
(/isis/citation/CBB000932553/)
Article
Christine Y. L. Luk;
(2016)
Biotech in Hong Kong: How Biologist-Entrepreneurs Pursued “Hong Kong's Bioscience Dream”
(/isis/citation/CBB136935289/)
Article
Christine Y. L. Luk;
(2016)
Biotech in Hong Kong: How Biologist-Entrepreneurs Pursued “Hong Kong's Bioscience Dream”
(/isis/citation/CBB983059184/)
Book
Liyanage, Shantha;
Wink, Rüdiger;
Nordberg, M.;
(2007)
Managing Path-Breaking Innovations: CERN-ATLAS, Airbus, and Stem Cell Research
(/isis/citation/CBB000950885/)
Chapter
Gaudillière, Jean-Paul;
(2019)
From Crisis to Reformulation: Innovation in the Global Drug Industry and the Alternative Modernization of Indian Ayurveda
(/isis/citation/CBB918375599/)
Book
B. Zorina Khan;
(2020)
Inventing ideas : patents, prizes, and the knowledge economy
(/isis/citation/CBB655098948/)
Book
Catalina Toro Pérez;
Bravo Velásquez, E. (Elizabeth);
Germán Vélez;
(2014)
La ecología política de la bioseguridad en América Latina [The political ecology of biosafety in Latin America]
(/isis/citation/CBB677321582/)
Article
Fabrício Monteiro Neves;
(2022)
Some elements of the regime of management of irrelevance in science
(/isis/citation/CBB498387701/)
Article
Poonam Pandey;
Aviram Sharma;
(2017)
NGOs, Controversies, and “Opening Up” of Regulatory Governance of Science in India
(/isis/citation/CBB915250388/)
Book
Sheila Jasanoff;
Sang-Hyun Kim;
(2015)
Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power
(/isis/citation/CBB690565115/)
Article
Avinash Kumar;
Sambit Mallick;
(2020)
Interests, Norms, Meanings: A Study of Rice Biotechnology in India
(/isis/citation/CBB980442365/)
Article
Alyssa Botelho;
(2021)
The Insights of Radical Science in the CRISPR Gene-Editing Era: A History of Science for the People and the Cambridge Recombinant DNA Controversy
(/isis/citation/CBB000261857/)
Article
Kean Birch;
(May 2017)
Rethinking Value in the Bio-economy: Finance, Assetization, and the Management of Value
(/isis/citation/CBB133617956/)
Article
Jonas Rüppel;
Torsten H. Voigt;
(2019)
The Death of the Clinic? Emerging Biotechnologies and the Reconfiguration of Mental Health
(/isis/citation/CBB246876726/)
Book
Charles Lawson;
Berris Charnley;
(2015)
Intellectual Property and Genetically Modified Organisms: A Convergence in Laws
(/isis/citation/CBB742382287/)
Be the first to comment!